Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Treatment of tardive dyskinesia. II. Short-term efficacy of dopamine-blocking agents haloperidol and thiopropazate.

× No keyword cloud information.

18 in total

1. Tardive dyskinesia during and following treatment with haloperidol, haloperidol + biperiden, thioridazine, and clozapine.

Authors: J Gerlach; H Simmelsgaard
Journal: Psychopharmacology (Berl) Date: 1978-10-31 Impact factor: 4.530

2. Tardive dyskinesia: therapeutic options for an increasingly common disorder.

Authors: Leslie J Cloud; Deepti Zutshi; Stewart A Factor
Journal: Neurotherapeutics Date: 2014-01 Impact factor: 7.620

Review 3. Tardive Dyskinesia Associated with Atypical Antipsychotics: Prevalence, Mechanisms and Management Strategies.

Authors: Katharina Stegmayer; Sebastian Walther; Peter van Harten
Journal: CNS Drugs Date: 2018-02 Impact factor: 5.749

Review 4. Orofacial dyskinesia. Clinical features, mechanisms and drug therapy.

Authors: R M Kobayashi
Journal: West J Med Date: 1976-10

5. What's new in the psychopharmacology of schizophrenia.

Authors: A Rifkin; F Quitkin
Journal: Bull N Y Acad Med Date: 1978-10

6. Treatment Recommendations for Tardive Dyskinesia.

Authors: Lucia Ricciardi; Tamara Pringsheim; Thomas R E Barnes; Davide Martino; David Gardner; Gary Remington; Donald Addington; Francesca Morgante; Norman Poole; Alan Carson; Mark Edwards
Journal: Can J Psychiatry Date: 2019-02-21 Impact factor: 4.356

7. Oxiperomide in tardive dyskinesia.

Authors: D E Casey; J Gerlach
Journal: J Neurol Neurosurg Psychiatry Date: 1980-03 Impact factor: 10.154

8. Fluperlapine in tardive dyskinesia and parkinsonism.

Authors: S Korsgaard; U Noring; J Gerlach
Journal: Psychopharmacology (Berl) Date: 1984 Impact factor: 4.530

9. Effect of different neuroleptics in tardive dyskinesia and parkinsonism. A video-controlled multicenter study with chlorprothixene, perphenazine, haloperidol and haloperidol + biperiden. Nordic Dyskinesia Study Group.

Authors:
Journal: Psychopharmacology (Berl) Date: 1986 Impact factor: 4.530

10. Neuroleptic-induced vacuous chewing movements in rodents: incidence and effects of long-term increases in haloperidol dose.

Authors: M F Egan; T M Hyde; J E Kleinman; R J Wyatt
Journal: Psychopharmacology (Berl) Date: 1995-01 Impact factor: 4.530